Taiwan FDA registration 7351a9f4270ee7aa1f7e5197abc1f511
Imin 17α-Hydroxyprogesterone radioimmunoassay reagent
TW: 伊敏17α-羥基黃體脂酮放射免疫分析試劑
Taiwan·Risk Class 2·SIEMENS HEALTHCARE DIAGNOSTICS INC.·Registered Aug 08, 2011 – Aug 08, 2016CancelledRegistration details
- Analysis ID
- 7351a9f4270ee7aa1f7e5197abc1f511
- Customs Code
- DHAS0602253605
Company information
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS INC.
- Manufacturer Country
- United States
- Authorized Representative
- ALICE LEE INDUSTRIES CO., LTD.
Product details
- Intended Use
- Radioimmunoassay was used to quantitatively detect 17α-hydroxyluteinous progesterone in human serum and plasma in vitro
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1395 17-Progesterone Test System
- Import Information
- Input;; Consent letter must be attached to the import (consent from the Atomic Energy Commission must be obtained for each import)
Dates and status
- Registration Date
- Aug 08, 2011
- Expiry Date
- Aug 08, 2016
- Cancellation Date
- Jul 31, 2018
Cancellation information
- Status
- Logged out
- Reason
- 未展延而逾期者
About this record
Access comprehensive regulatory information for Imin 17α-Hydroxyprogesterone radioimmunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7351a9f4270ee7aa1f7e5197abc1f511 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is ALICE LEE INDUSTRIES CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices